DANA Inc has announced its third-quarter financial results, showcasing a robust performance that highlights the company's operational efficiency and strategic initiatives. With sales reaching $2.04 billion, the company reported a net income of $15 million. This positive outcome is attributed to increased demand in the commercial vehicle sector and effective cost management strategies.

The filing, dated October 28, 2026, reveals that DANA's sales increased by $121 million compared to the same quarter in 2025. Adjusted EBITDA for the quarter was $218 million, reflecting a margin of 10.7%, up from 8.5% in the previous year. These figures indicate a significant improvement in profitability, driven by productivity gains and cost-saving measures.

Background

DANA Inc, incorporated in Delaware, operates in the motor vehicle parts and accessories industry, classified under SIC code 3714. The company trades on the New York Stock Exchange under the ticker symbol DAN. DANA has been active in the market with recent filings, including an 8-K on October 28, 2026, detailing its financial performance and strategic plans.

What the Filing Says

The SEC filing outlines DANA's results for the quarter ending September 30, 2026. It states, "Sales in the third quarter of 2026 totaled $2.04 billion, compared with $1.92 billion in the same period of 2025." Additionally, it mentions that the company repurchased approximately 6.6 million shares for $200 million during the quarter.

Impact

This update may affect shareholders and investors, as DANA's strong financial results and increased share repurchases signal confidence in the company's future. The positive performance could also influence competitors in the motor vehicle parts and accessories sector, prompting them to enhance their own operational strategies to remain competitive.

What's Next

DANA has indicated plans for additional share repurchases, estimating around $100 million in the fourth quarter of 2026. The company is also on track to complete the Eaton Mobility transaction, with nearly all regulatory approvals obtained.